Shiha, G., Aboud, A., Mahmoud Khalil, D., Salama Sieddek, A. (2019). Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt. Medical Journal of Viral Hepatitis, 4.1(1), 45-52. doi: 10.21608/mjvh.2019.59526
Gamal Shiha; Alaa Aboud; Doaa Mahmoud Khalil; Asmaa Salama Sieddek. "Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt". Medical Journal of Viral Hepatitis, 4.1, 1, 2019, 45-52. doi: 10.21608/mjvh.2019.59526
Shiha, G., Aboud, A., Mahmoud Khalil, D., Salama Sieddek, A. (2019). 'Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt', Medical Journal of Viral Hepatitis, 4.1(1), pp. 45-52. doi: 10.21608/mjvh.2019.59526
Shiha, G., Aboud, A., Mahmoud Khalil, D., Salama Sieddek, A. Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt. Medical Journal of Viral Hepatitis, 2019; 4.1(1): 45-52. doi: 10.21608/mjvh.2019.59526
Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt
1Internal Medicine dept., Mansoura Univ.; Egyptian Liver Research Institute and Hospital (ELRIH), Sherbin, El-Mansoura, Egypt
2Internal Medicine dept., Mansoura Univ., Egypt
3Public health and community medicine dept., Faculty of Medicine, Beni- Suef Univ., Egypt.
4Tropical Medicine dept., Faculty of Medicine, Beni-Suef Univ., Egypt,
Abstract
Background and aims. Liver biopsy is the gold standard for diagnosis and staging of liver fibrosis, but it is invasive and has many complications that diminished its practice. Now, robust of non-invasive index for predicting fibrosis is very valuable. The aim of this study is to validate and determine the efficacy of noninvasive markers aspartate aminotransferase to platelet ratio (APRI), FIB4 and AFP versus Fibroscan for predicting the fibrosis stages of patients with chronic HCV infection. Methods: This crosssectional study included 621 patients with chronic hepatitis C infection attended out-patient clinic (Medical center Beni-Suef branch, the association of liver patient care, ELP, El-Mansoura) for HCV viral hepatitis treatment. The patients were diagnosed by RT-PCR. Sensitivity and specificity of APRI, FIb-4 and AFP were estimated by receiver operator characteristic curve (ROC) for predicting stage of fibrosis versus Fibroscan. Results: Compared to Fibroscan as standard at value 12 kPa, the sensitivity and specificity of APRI was (67% and 61% and AUC= 0.747), of FIb-4 was (77% and 72% and AUC = 0.769) and of AFP was (77% and 60% and AUC = 0.734) for predicting early stages of fibrosis (F0-F1-F2). However, with advanced liver fibrosis (F3-F4) compared to Fibroscan at value 15 kPa, the sensitivity and specificity of APRI was (100% and 95.3% and AUC= 0.960) and of FIb-4 was (100% and 87.4% and AUC= 0.879) and of AFP were (100% and 51% and AUC= 0.684) for predicting F4 fibrosis. Conclusion: Given the higher cost and reduced availability of Fibroscan, this study showed that, the non-invasive tests APRI, FIB-4 index and AFP are practically useful markers for diagnosis and monitoring of liver fibrosis among patients with chronic HCV patients especially with advanced liver fibrosis.
View on SCiNiTO
Top